These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4988833)

  • 1. [The yeast Saccharomyces cerevisiae can become an immunity factor and inhibit graft of Sartorelli ascitic sarcoma TG 180 in mice].
    Vermeil C; Morin O
    C R Acad Hebd Seances Acad Sci D; 1970 Jul; 271(3):378-80. PubMed ID: 4988833
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytophilic activity associated with murine allogeneic tumor rejection.
    Mazzolli AB; Barrera CN; Colmerauer ME; Pasqualini CD
    Medicina (B Aires); 1978; 38(6 Pt 1):639-42. PubMed ID: 374929
    [No Abstract]   [Full Text] [Related]  

  • 3. Modification by passive IgM of the immune response of mice to a tumor allograft.
    Cantrell JL; Kaliss N
    J Natl Cancer Inst; 1974 May; 52(5):1619-25. PubMed ID: 4831447
    [No Abstract]   [Full Text] [Related]  

  • 4. Complete in vivo destruction of allografted sarcoma I cells by circulating antibodies.
    Kinsky R; Chouroulinkov I; Voisin GA
    Transplantation; 1970 Nov; 10(5):450-1. PubMed ID: 5490529
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunity to transplantable carcinogen induced fibrosarcomas in B2/B2 chickens. II. Macrophage dependency of adoptive T cell mediated tumor immunity.
    Palladino MA; Thorbecke GJ
    Cell Immunol; 1978 Jul; 38(2):350-64. PubMed ID: 307987
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody-mediated immunity to transplantable tumors following reovirus oncolysis.
    Klein PA
    Pathol Microbiol (Basel); 1967; 30(2):222-45. PubMed ID: 4291735
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of carcinogenesis by murine sarcoma virus (Harvey) following injections of immune sera during the latent period.
    Bubeník J; Turano A; Fadda G
    Int J Cancer; 1969 Sep; 4(5):648-54. PubMed ID: 4310638
    [No Abstract]   [Full Text] [Related]  

  • 9. A factor preventing the development of lung metastases in rats with sarcomas.
    Proctor JW; Rudenstam CM; Alexander P
    Nature; 1973 Mar; 242(5392):29-31. PubMed ID: 4694291
    [No Abstract]   [Full Text] [Related]  

  • 10. Observations with a variant of lymphocytic choriomeningitis virus in mouse tumors.
    Eiselein J; Biggs MW
    Cancer Res; 1970 Jul; 30(7):1953-7. PubMed ID: 4989547
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients.
    Peters LJ; McBride WH; Mason KA; Hunter N; Basić I; Milas L
    J Natl Cancer Inst; 1977 Sep; 59(3):881-7. PubMed ID: 330869
    [No Abstract]   [Full Text] [Related]  

  • 12. The transfer of tumor immunity with syngeneic RNA.
    Deckers PJ; Ramming KP; Pilch YH
    Ann N Y Acad Sci; 1973 May; 207():442-53. PubMed ID: 4517720
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor cell threshold required for suppression of macrophage inflammation.
    Normann SJ
    J Natl Cancer Inst; 1978 May; 60(5):1091-6. PubMed ID: 417187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of immunity to tumour isografts by the systemic administration of xenogeneic "immune" RNA.
    Deckers PJ; Pilch YH
    Nat New Biol; 1971 Jun; 231(23):181-3. PubMed ID: 5281197
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of immunity toward allogeneic tumors in mice. II. Effect of antiserum and antiserum fractions on cellular and humoral response.
    Takasugi M; Hildemann WH
    J Natl Cancer Inst; 1969 Oct; 43(4):857-67. PubMed ID: 5344182
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison between the effect of rabbit anti-rat lymphocyte sera raised by thymus, thoracic duct, and spleen lymphocytes on second-set tumor allograft in the rat.
    Girardet RE; Glass N; Patti J; Gardner B
    J Surg Res; 1971 Sep; 11(9):433-40. PubMed ID: 5094737
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospects for tumor immunotherapy in man, with emphasis on its use as an adjunct to surgery for primary operable cancer.
    Southam CM
    J Med Liban; 1975; 28(1):43-66. PubMed ID: 1107552
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of the graft-versus-host reaction on transplantation immunity to homologous tumors].
    Semenkov VF; Shevelev AS
    Vopr Onkol; 1971; 17(6):69-73. PubMed ID: 4400328
    [No Abstract]   [Full Text] [Related]  

  • 19. [Induction of an immunity against plasma cell sarcoma graft in the mouse BALB-c].
    Lespinats G
    Eur J Cancer (1965); 1969 Nov; 5(5):421-6. PubMed ID: 5366971
    [No Abstract]   [Full Text] [Related]  

  • 20. Ribonucleic acid-mediated inhibition and enhancement of tumor growth in mice.
    Ramming KP; Pilch YH
    Surg Forum; 1969; 20():106-9. PubMed ID: 5383020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.